Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
EyeTechCare Doubles the Number of Health Care Facilities in France with the EyeOP1 Device
Thursday, January 02, 2014
The EyeOp1 device is now available in ten centers across France, with this figure expected to double in 2014.
TELOS MicroPlate™ from Kinesis – a versatile 96-well SPE format for small volume biological fluid samples
Monday, December 16, 2013
The TELOS MicroPlate™ is a versatile 96-well plate for the extraction of drug molecules from small volume biological fluid samples.
New UK mHealth Congress Announced for 2014
Tuesday, November 19, 2013
MCT-Congress will bring together key influencers to drive the business of mHealth in clinical research.
Phenom-World Launches the New Particlemetric Software for Fully Automated Inspection and Analysis of Particles
Tuesday, November 12, 2013
With the introduction of the ParticleMetric software, the visualization and analysis of particles are easier than ever before with the Phenom desktop SEM.
Nov 20 Best Practices IV: Preclinical Outsourcing Program/Simulcast
Monday, November 11, 2013
Preclinical outsourcing program/simulcast at Ocean Place in Long Branch, NJ, and via Webinar.
Quotient Clinical at AAPS 2013
Friday, November 08, 2013
AAPS annual meeting and exposition to be held in San Antonio, Texas, from the 10th to the 14th of November.
Aesica Introduces Aseptic Micro Dosing Capabilities at Nottingham Site
Tuesday, November 05, 2013
New technology (3P Fill2Weight) reduces development cycle and can be used with capsules, vials, inhalers, injectables, blisters and even high potents.
Aptiv Solutions ADDPLAN® DF is the First Validated Software to Use MCP-Mod Methodology
Thursday, October 31, 2013
MCP-Mod methodology was recently qualified by EMA for reducing bias and error in dose finding clinical trials.
Cobra Biologics Expands Antibody GMP Production Capacity
Tuesday, October 29, 2013
Company installs new 1000L HyClone SUB at the company’s centre of excellence.
Showing Results 61 - 70 of 318
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,900+ scientific and medical posters
4,200+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!